Dell vs Roche: Founders, CEOs and History
Dell was founded in 1984 by Michael S. Dell and is led by Michael S. Dell. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.
Company facts
Founders
Dell
Michael S. Dell
Dell Technologies possesses one of the most famous, foundational founding stories in the history of the personal computer revolution, rooted in an aggressive, direct-to-consumer arbitrage strategy executed entirely from a college dorm room.
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
CEOs and their tenures
Dell
- Michael S. Dell1984–present
Founder, Chairman, and Chief Executive Officer
Michael Dell's bold, aggressive strategic maneuvers transformed the company from a successful consumer PC manufacturer into a global leader in complex enterprise data center infrastructure and advanced cloud computing.
Source - Kevin Rollins2004–2007
President and Chief Executive Officer
As CEO from 2004 to 2007, he oversaw a period of severe stagnation, losing the company's #1 PC market share position to HP, forcing Michael Dell to return and retake control.
Source - Jeff Clarke2017–present
Vice Chairman and Chief Operating Officer
As Vice Chairman and Co-COO, he is the primary operational architect of Dell's Infrastructure Solutions Group, transforming the company from a PC maker into a massive enterprise IT vendor.
Source - David Kennedy2025–present
Chief Financial Officer
As Chief Legal Officer, he navigated the highly contentious 2013 leveraged buyout that took the company private, and the equally complex 2018 transaction that returned it to the public markets.
Source
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Timeline: Dell and Roche side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
1984Dell
PC's Limited Founded
Michael Dell starts PC's Limited from his University of Texas dorm room using a direct-sales PC model.
1988Dell
Dell Goes Public
Dell Computer Corporation completes its initial public offering and scales internationally.
2001Dell
Dell Becomes Largest PC Maker
Dell becomes the world's largest PC maker by market share, validating the direct model at global scale.
2007Dell
Michael Dell Returns as CEO
Michael Dell returned as chief executive in January 2007, replacing Kevin Rollins.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2013Dell
Dell Goes Private
Michael Dell and Silver Lake take Dell private in a leveraged buyout to reposition the company away from public-market pressure.
2016Dell
EMC Acquired
Dell completes the EMC acquisition, creating Dell Technologies and expanding into enterprise storage, infrastructure, and VMware-linked assets.
2018Dell
Dell Returns to Public Markets
Dell Technologies returns to public-market trading through a complex transaction involving its VMware tracking stock.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2021Dell
VMware Spin-Off
Dell completes the VMware spin-off, simplifying the corporate structure and reducing debt.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2025Dell
PC Brands Simplified
Dell introduces simplified Dell, Dell Pro and Dell Pro Max PC brand tiers at CES 2025.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Dell
Record $113.5B Fiscal Year
Dell reports record fiscal 2026 revenue of $113.5B, $64.1B of AI server orders and a $43B AI backlog.
2026Dell
$95B AI Server Backlog
Q2 fiscal 2027 revenue rises 58% to $47.0B; AI orders hit $60.9B and backlog reaches $95B; full-year guidance raised to about $192B.
Acquisitions
Dell
- EMC Corporation2016$67B
- Quest Software2012$2.4B
- Perot Systems2009$3.9B
- Alienware2006Undisclosed
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Questions about Dell vs Roche
Who is the CEO of Dell Technologies Inc. and F. Hoffmann-La Roche AG?
Dell Technologies Inc. is led by Michael S. Dell and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Dell Technologies Inc. founded vs F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG was founded in 1896 — 88 years before Dell Technologies Inc., which was founded in 1984. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Dell Technologies Inc..
How many employees does Dell Technologies Inc. have compared to F. Hoffmann-La Roche AG?
Dell Technologies Inc. employs approximately 97,000 people, while F. Hoffmann-La Roche AG employs approximately 112,774. F. Hoffmann-La Roche AG has the larger workforce at 112,774 employees, compared to Dell Technologies Inc.'s 97,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Dell Technologies Inc. and F. Hoffmann-La Roche AG headquartered?
Dell Technologies Inc. is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded Dell Technologies Inc. and F. Hoffmann-La Roche AG?
Dell Technologies Inc. was founded by Michael S. Dell. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.
Which company has a longer operating history — Dell Technologies Inc. or F. Hoffmann-La Roche AG?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Dell Technologies Inc. has been in operation for around 42 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Dell vs Roche overview